A Case of Gemcitabine-Induced Thrombotic Microangiopathy Treated With Ravulizumab in a Patient With Stage IV Pancreatic Cancer

A 47-year-old male with stage IV pancreatic cancer developed gemcitabine-induced thrombotic microangiopathy (GiTMA) after treatment with gemcitabine and nab-paclitaxel. GiTMA is a rare and life-threatening complication with an incidence ranging from 0.015% to 1.4% and reported mortality rate ranging...

Descripción completa

Detalles Bibliográficos
Autores principales: MacDougall, Kira N, Schwartz, Benjamin, Harewood, Janine, Bukhari, Zaheer, Neculiseanu, Elvira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931775/
https://www.ncbi.nlm.nih.gov/pubmed/33680585
http://dx.doi.org/10.7759/cureus.13031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931775/
https://www.ncbi.nlm.nih.gov/pubmed/33680585
http://dx.doi.org/10.7759/cureus.13031

Ejemplares similares